Clinical trial Recruiting at 1 site Interventional Ages 18 to 90 Women only

Preventing lung complications after gynecologic surgery using high-flow nasal oxygen

Official title: A Randomized Controlled Trial on the Preventive Effect of Heated Humidified High Flow Nasal Cannula Oxygen Therapy on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms

Run by Sichuan Cancer Hospital and Research Institute · NCT05526534 · Data updated 2026-11-12

This study is testing if high-flow nasal oxygen can help prevent lung problems after gynecologic surgery in patients who are at high risk for these issues.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexWomen only
Enrollment200 (estimated)
SponsorSichuan Cancer Hospital and Research Institute
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedNovember 1, 2022
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedMay 23, 2025
Trial IDNCT05526534 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients aged 18 to 90 with gynecologic neoplasms who are at high risk for postoperative pulmonary complications.

Probably not a fit

Patients with lung metastasis, previous lung surgery, or those undergoing segmental bowel resection may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of high-flow nasal cannula (HFNC) oxygen therapy in preventing postoperative pulmonary complications in patients undergoing gynecologic surgery. Patients at high risk for these complications will be randomly assigned to receive either HFNC or conventional nasal cannula oxygen therapy. The primary outcome measured will be the incidence of postoperative pulmonary complications such as hypoxemia, atelectasis, and pneumonia, while secondary outcomes will include improvements in oxygenation, antibiotic use, length of hospital stay, and any adverse events related to the oxygen therapy. The study will enroll patients aged 18 to 90 with specific respiratory risk factors.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of postoperative pulmonary complications in high-risk patients undergoing gynecologic surgery.

How similar studies have gone: Other studies have shown promising results with high-flow nasal cannula therapy in similar patient populations, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with gynecologic Neoplasms, including benign gynecologic tumors and malignant gynecologic tumors, who are 18 to 90 years old and are scheduled for surgical treatment in our center shall receive plain chest CT scan within 1 week before surgery, and the estimated surgical time shall be ≥2 hours, and at least one of the following conditions shall be met:

  1. Assess respiratory risk in surgical patients in Catalonia (ARRSPC) ≥45 points;
  2. BMI≥30;
  3. Moderate to severe asthma;
  4. Moderate to severe chronic obstructive pulmonary disease (COPD);
  5. Smoking history ≥20 packs/year

Exclusion Criteria:

1. Patients with lung metastasis of malignant tumor or primary lung malignant tumor;
2. previous lung surgery or radiotherapy;
3. the surgery involved segmental bowel resection.

Where it's running

  • Sichuan Cancer Hospital and Research Institute
    Chengdu, Sichuan, China
    Recruiting

Study contacts

  • Principal investigator: Dengfeng Wang, M.D. — Sichuan Cancer Hospital and Research Institute
  • Study coordinator: Dengfeng Wang, M.D.
  • Email: wonderful_96@163.com
  • Phone: +86 159 82222707

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.